DGAP-Adhoc: ​​​​​​​Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20%


 

DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Change in Forecast/Half Year Results
​​​​​​​Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20%

27-Jul-2021 / 17:27 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Berlin, 27 July 2021. Based on initial, unaudited assessments, earnings of Berlin-based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) for the half year ending 30 June 2021 are higher than expected. The consolidated result in the first half of the year came up to approximately 22 mm EUR (previous year: 13 mm EUR), in sum already exceeding 75% of the guidance given for the full business year.

Based on these preliminary results the Executive Board expects the consolidated result for the financial year 2021 to exceed the forecast published at the beginning of the year by approximately 20%. It therefore rescinds the previous guidance and increases the full year net profit target from 29 mm to approximately 35 mm EUR and the EPS target from 1.40 EUR to approximately 1.70 EUR. Sales Revenues are expected to remain at the previous year's level of around 180 mm EUR.

The complete figures for the first half year 2021 will be published on 12 August 2021.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com


27-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1222089

 
End of Announcement DGAP News Service

1222089  27-Jul-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1222089&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 139,75 137,94 138,63 168,71 178,49 176,14 178,00
EBITDA1,2 26,98 24,97 26,62 32,14 43,13 44,64 0,00
EBITDA-Marge3 19,31 18,10 19,20 19,05 24,16 25,34 0,00
EBIT1,4 18,22 16,23 17,97 23,39 32,06 33,69 0,00
EBIT-Marge5 13,04 11,77 12,96 13,86 17,96 19,13 0,00
Jahresüberschuss1 10,37 9,79 15,12 16,89 22,48 23,11 29,60
Netto-Marge6 7,42 7,10 10,91 10,01 12,59 13,12 16,63
Cashflow1,7 16,23 19,83 26,83 21,21 40,43 36,79 0,00
Ergebnis je Aktie8 0,51 0,45 0,70 0,78 1,07 1,11 1,70
Dividende8 0,15 0,17 0,20 0,30 0,42 0,45 0,48
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 126,300 Halten 2.674,02
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
65,44 20,61 3,17 173,97
KBV KCV KUV EV/EBITDA
19,30 72,69 15,18 58,34
Dividende '19 in € Dividende '20e in € Div.-Rendite '20e
in %
Hauptversammlung
0,42 0,45 0,36 02.06.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
11.05.2021 12.08.2021 09.11.2021 30.03.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
5,81% 50,90% 181,67% 195,09%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei DGAP abrufen

Medtech , 565970 , EUZ , XETR:EUZ